Agustin Melian - 04 Oct 2021 Form 4 Insider Report for Allovir, Inc. (KLRS)

Role
Chief Medical Officer
Signature
/s/ Brett Hagen, as Attorney-in-Fact
Issuer symbol
KLRS
Transactions as of
04 Oct 2021
Net transactions value
-$446,862
Form type
4
Filing time
05 Oct 2021, 21:05:54 UTC
Previous filing
29 Sep 2021
Next filing
12 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALVR Common Stock Sale $248,690 -10,678 -2.3% $23.29* 461,540 04 Oct 2021 Direct F1, F2
transaction ALVR Common Stock Sale $114,129 -4,711 -1% $24.23* 456,829 04 Oct 2021 Direct F1, F3
transaction ALVR Common Stock Sale $75,377 -2,967 -0.65% $25.41* 453,862 04 Oct 2021 Direct F1, F4
transaction ALVR Common Stock Sale $8,666 -333 -0.07% $26.02* 453,529 04 Oct 2021 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock, and does not represent a discretionary trade by the reporting person.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.78 to $23.77. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.78 to $24.77. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F4 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.78 to $25.75. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F5 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.795 to $26.38. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.